Hot Life Science Investor Mandate 3: Corporate VC of Large Chinese Conglomerate Seeking Healthcare IT Investments in US and China

16 Jul

A large Chinese conglomerate with approximately USD 50 billion AUM makes direct investments into early stage healthcare IT space via a specialized corporate VC fund. The fund can invest anywhere from US$ 1 million up to $50 million, depending on the deal. Operating from its headquarter in Shanghai, China with an additional office in San Francisco, the firm is currently seeking opportunities in China and the United States.

Within healthcare IT, the firm focuses on consumer-facing mobile and internet companies with large market potential. Examples include telemedicine and patient-doctor interface than lower healthcare costs; data and specimen management systems that improves healthcare workflow; and consumer-oriented biomarker and molecular diagnostic tools. The firm is interested in technologies that can be applied to the Chinese market; however this is not a requirement for investment.

For overseas opportunities, the firm is interested in highly reputable management teams with strong record of success. The firm typically acts as lead investor in a financing round and seeks a board seat after investment.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: